A study of prevalence of hyperlipidaemia metabolic syndrome and IHD among hypertensive patients at tertiary health care centre

 

G Vijay Kumar¹, Vivek kumar Reddy^2*, A Sweetha Rani³

 

REFERENCES

1. Meigs JB: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152: 908–911.
2. Timar O, Sestier F, Levy E: Metabolic syndrome X: A review. Can J Cardiol 2000; 16: 779–789.
3. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473–486.
4. Granbury MC, Foneseca VA: Insulin resistance syndrome: Options for treatment. South Med J 1999; 92: 2–15.
5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
6. Scheen AJ, Lefebvre PJ: Insulin action in man. Diabetes Metab1996;22:105–110
7. Muller-Wieland D, Krone W: Disorders of lipid metabolism in insulin resistance. Herz 1995; 20:33–46.
8. Kylin E: Studies of the hypertensionhyperglycemia-hyperuricemia syndrome (Studienueber das hypertonie-hyperglyka¨mie-hyperurika¨miesyndrom.) ZentralblattfuerInnereMedizin 44:105–127, 1923
9. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595–1607, 1988
10. Meigs JB: Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors (Review). Am J Epidemiol 152:908–911, 2000
11. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689, 2001
12. Trevisan M, Liu J, Bahsas FB, Menotti A: Syndrome X and mortality: a populationbased study: Risk Factor and Life Expectancy Research Group. Am J Epidemiol 148: 958–966, 1998
13. Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB: Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159:1104–1109, 1999
14. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41: 715–722, 1992
15. Surender Thakur, Sujeet Raina Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India.Indian J Endocrinol Metab. 2013 Jul-Aug; 17(4): 723–726.
16. S. Harikrishnan et al. Prevalence of metabolic syndrome and its risk factors in Kerala, South India: Analysis of a community based cross-sectional study.PLoS One. 2018; 13(3): e0192372.